Quality Investor

UiPath, Inc.

Rank #104Capital ReturnWatchlistCompare with other stocks

PATH · NYSE · Technology

UiPath, Inc. (PATH) — Rank #104 by gross profitability (GP/assets 0.46) · ROE 14.5% · Piotroski F-Score 7 / 9.

As-of 2026-10-30 · CIK 0001734722 · all metrics point-in-time as of the filing date.

About

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally.

Show more

It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent builder; RPA and API automation; UiPath intelligent xtraction and processing; UiPath test cloud for testing and quality assurance; UiPath packaged and prebuilt agentic solutions; and centralized governance capabilities that apply across automations, AI agents, and manual tasks. It serves the financial services, healthcare, manufacturing, retail, and public sectors.

The company was founded in 2005 and is headquartered in New York, New York.

Industry
Software - Infrastructure
Sector
Technology
State
DE
Filer Category
Large accelerated filer
Fiscal Year End
January 31
Website
uipath.com

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

3,981

Industry

Software - Infrastructure

Exchange

NYSE

12/12

Flags passed

PATH passes 12/12 quality flags

  • PASS
    Gross margin holding
  • PASS
    Dilution within 2%
  • PASS
    FCF not negative from investment
  • PASS
    Disclosure consistent
  • PASS
    Revenue not declining
  • PASS
    Operating margin holding
  • PASS
    Free cash flow intact
  • PASS
    Passes safety gate
  • PASS
    Balance sheet stable
  • PASS
    No competitive retreat
  • PASS
    SBC not compressing margin
  • PASS
    No valuation convergence

Strengths Revenue growth accelerating · Deferred revenue growing · RPO outpacing revenue · Sequential beat (rev + EPS)

A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.

Quality Profile

Profitability

1/1 pass
GP / assets
0.46
Return on equity
14.5%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.49
Current ratio
2.39×
Net cash
$1.30B

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
18.0%

Growth

2/2 pass
Revenue growth
12.7%
Piotroski F-Score
7 / 9
Share dilution
-2.7%

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Does it make money well?

No warning flags · GP/assets 69th percentile of 36 SIC 7372 peers

Gross profitability (GP / assets)

0.46

Primary signal (Novy-Marx).

69th pctl of 36 SIC 7372 peers

Return on equity

14.5%

Gross margin

83.2%

97th pctl of 36 SIC 7372 peers

Revenue growth (YoY)

12.7%

RPO growth (YoY)

18.7%

Remaining performance obligations growth — RPO > revenue = forward demand building.

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2023202420252026
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

15.0%

Revenue CAGR (5Y)

21.5%

Earnings CAGR (3Y)

—

FCF CAGR (3Y)

—

Cash Flow Health

Is the cash real?

No warning flags · FCF 25% above net income

Free cash flow

$352.16M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF vs net income

24.7%

(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.

FCF not below net income

Fails when free cash flow is below net income (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

18.0%

Stock-based comp intensity.

Balance Sheet Strength

Can it survive a storm?

No warning flags · net cash $1.30B, F-Score 7/9

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.49

61st pctl of 32 SIC 7372 peers (best = lowest)

Current ratio

2.39×

66th pctl of 36 SIC 7372 peers

Quick ratio

1.97×

Net cash

$1.30B

Cash & equivalents minus total debt.

Piotroski F-Score

7 / 9

Fundamental-strength score (0-9).

Valuation

Is the price reasonable?

No warning flags

Capital allocation quality

Composite score

3.0 / 5

Good
Share count trend(net buybacks)
-2.7%4/5 Strong
Buyback timing
N/AN/A
Dividend growth consistency(non-payer or broken streak)
0 yr3/5 Good
Net debt trajectory
-4.9%2/5 Fair

Lifecycle Phase History

20212026
Hypergrowth
Startup
Capital Return

Price History

PATH-75.9% · -24.7% CAGRSPY+82.9% · +12.8% CAGR